effect of fractional Q switch laser compared with Nd:YAG laser in the treatment of active acne of face: a single-blind randomized clinical trial
Not Applicable
- Conditions
- Acne.L70.0Acne vulga
- Registration Number
- IRCT20170809035597N4
- Lead Sponsor
- Iran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Patient between 15 and 50 years old
Patients with a confirmed diagnosis of facial active acne
During the last 3 months, the patient has not received any treatment for the disease.
Lack of underlying disease
The patient's cooperation in carrying out therapeutic interventions and referring for all therapeutic sessions
Exclusion Criteria
The patient has been treated for acne in the last three months
The presence of a serious underlying disease in the person
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie the efficacy of fractional Q-switch laser in acne vulgaris treatment?
How does long-pulsed Nd:YAG 1064 nm laser compare to fractional Q-switch laser in acne vulgaris treatment outcomes?
What biomarkers correlate with response to laser therapy in patients with active acne vulgaris?
What are the potential adverse events associated with fractional Q-switch laser treatment for acne?
Are there combination therapies involving azithromycin and laser treatments that improve acne vulgaris management?